Industry Growth Insights published a new data on “Antihypertensive Market”. The research report is titled “Antihypertensive Market research by Types (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors), By Applications (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Players/Companies Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim, Bayer, Johnson & Johnson, Pfizer, Tekeda, Ranbaxy Laboratories, Shihuida Pharm, Second Pharmaceutical, Lupin Limited., Yangtze River Pharmaceutical, Hengrui Medicine, Qilu Pharmaceutical, HUALON, Dawnrays, HISUN Pharmceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antihypertensive Market Research Report
By Type
Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
By Companies
Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim, Bayer, Johnson & Johnson, Pfizer, Tekeda, Ranbaxy Laboratories, Shihuida Pharm, Second Pharmaceutical, Lupin Limited., Yangtze River Pharmaceutical, Hengrui Medicine, Qilu Pharmaceutical, HUALON, Dawnrays, HISUN Pharmceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Antihypertensive Market Report Segments:
The global Antihypertensive market is segmented on the basis of:
Types
Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Norvatis
- Merck & Co.
- Sanofi
- AstraZeneca
- GSK
- Daiichi-Sankyo
- Boehringer-Ingelheim
- Bayer
- Johnson & Johnson
- Pfizer
- Tekeda
- Ranbaxy Laboratories
- Shihuida Pharm
- Second Pharmaceutical
- Lupin Limited.
- Yangtze River Pharmaceutical
- Hengrui Medicine
- Qilu Pharmaceutical
- HUALON
- Dawnrays
- HISUN Pharmceutical
Highlights of The Antihypertensive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diuretics
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Beta Blockers
- Alpha Blockers
- Vasodilators & Renin Inhibitors
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antihypertensive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antihypertensive medications are used to lower blood pressure.
Some of the major companies in the antihypertensive market are Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim, Bayer, Johnson & Johnson, Pfizer, Tekeda, Ranbaxy Laboratories, Shihuida Pharm, Second Pharmaceutical, Lupin Limited., Yangtze River Pharmaceutical, Hengrui Medicine, Qilu Pharmaceutical, HUALON, Dawnrays, HISUN Pharmceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antihypertensive Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antihypertensive Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antihypertensive Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antihypertensive Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antihypertensive Market Size & Forecast, 2020-2028
4.5.1 Antihypertensive Market Size and Y-o-Y Growth
4.5.2 Antihypertensive Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diuretics
5.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
5.2.3 Angiotensin Receptor Blockers (ARBs)
5.2.4 Calcium Channel Blockers
5.2.5 Beta Blockers
5.2.6 Alpha Blockers
5.2.7 Vasodilators & Renin Inhibitors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antihypertensive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antihypertensive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diuretics
9.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
9.6.3 Angiotensin Receptor Blockers (ARBs)
9.6.4 Calcium Channel Blockers
9.6.5 Beta Blockers
9.6.6 Alpha Blockers
9.6.7 Vasodilators & Renin Inhibitors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diuretics
10.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
10.6.3 Angiotensin Receptor Blockers (ARBs)
10.6.4 Calcium Channel Blockers
10.6.5 Beta Blockers
10.6.6 Alpha Blockers
10.6.7 Vasodilators & Renin Inhibitors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diuretics
11.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
11.6.3 Angiotensin Receptor Blockers (ARBs)
11.6.4 Calcium Channel Blockers
11.6.5 Beta Blockers
11.6.6 Alpha Blockers
11.6.7 Vasodilators & Renin Inhibitors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diuretics
12.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
12.6.3 Angiotensin Receptor Blockers (ARBs)
12.6.4 Calcium Channel Blockers
12.6.5 Beta Blockers
12.6.6 Alpha Blockers
12.6.7 Vasodilators & Renin Inhibitors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diuretics
13.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
13.6.3 Angiotensin Receptor Blockers (ARBs)
13.6.4 Calcium Channel Blockers
13.6.5 Beta Blockers
13.6.6 Alpha Blockers
13.6.7 Vasodilators & Renin Inhibitors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antihypertensive Market: Competitive Dashboard
14.2 Global Antihypertensive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Norvatis
14.3.3 Merck & Co.
14.3.4 Sanofi
14.3.5 AstraZeneca
14.3.6 GSK
14.3.7 Daiichi-Sankyo
14.3.8 Boehringer-Ingelheim
14.3.9 Bayer
14.3.10 Johnson & Johnson
14.3.11 Pfizer
14.3.12 Tekeda
14.3.13 Ranbaxy Laboratories
14.3.14 Shihuida Pharm
14.3.15 Second Pharmaceutical
14.3.16 Lupin Limited.
14.3.17 Yangtze River Pharmaceutical
14.3.18 Hengrui Medicine
14.3.19 Qilu Pharmaceutical
14.3.20 HUALON
14.3.21 Dawnrays
14.3.22 HISUN Pharmceutical
